Ghent, Belgium, 7 August 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback